Presentation illuminated the important synergistic interactions of VistaGen's stem cell-derived human cardiomyocytes and Duke's tissue engineering and analytical technologies.
http://www.prweb.com/releases/2012/11/prweb10109204.htm
http://www.prweb.com/releases/2012/11/prweb10109204.htm
No comments:
Post a Comment